Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Esophageal Neoplasms × CP protocol × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

Cisplatin 7 Radiotherapy 5 Paclitaxel 3 Fluorouracil 3 Capecitabine 3 S 1 (combination) 2 tegafur-gimeracil-oteracil 1 nimotuzumab 1 nedaplatin 1 apatinib 1 TP protocol 1 Surgical Procedures, Operative 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Immunotherapy 1 Fluorodeoxyglucose F18 1 Drug Therapy 1 Cetuximab 1 Carboplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01404156 2024-08-28

POWERRANGER

CancerCare Manitoba

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡